CD4 and colitis: Importantly, in vivo treatment with FANA-CD39-AS oligonucleotides results in a more favorable course of TNBS colitis induced in immunodeficient NOD/scid/gamma mice, previously re-populated using human CD4 cells with CD39-AS RNA expression.